Loading fund overlap…
8 of 91 unique stocks in common · Jaccard: 8.8%
A weighted portfolio overlap of 8.35% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹8.35 is allocated to the exact same companies at the same relative proportions. The schemes share 8 common holdings.
The largest overlapping asset in their portfolios is Cipla, which commands a weight of 2.89% in HDFC Flexi Cap Fund and 5.00% in Kotak Healthcare Fund. Holding both schemes increases your concentration in Cipla rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in HDFC | in Kotak |
|---|---|---|
| CiplaPharmaceuticals & Biotechnology | 2.89% | 5.00% |
| Max Healthcare InstituteHealthcare Services | 1.38% | 5.43% |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 1.18% | 5.95% |
| LupinPharmaceuticals & Biotechnology | 0.74% | 2.63% |
| Dr. Lal Path LabsHealthcare Services | 0.66% | 1.26% |
| Apollo Hospitals EnterpriseHealthcare Services | 0.58% | 2.92% |
| Anthem BiosciencesPharmaceuticals & Biotechnology | 0.57% | 2.44% |
| Metropolis HealthcareHealthcare Services | 0.35% | 1.09% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.